Xtant Medical Holdings, Inc. SEC filings XTNT

Xtant Medical Holdings, Inc. has 1,000 filings in SEC EDGAR's recent list, going back to Aug 1, 2011. Its latest annual report, Form ARS, was filed on Jun 23, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 11, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 11, 2026 (results of operations). The company's fiscal year ends on December 31.

Xtant Medical Holdings, Inc. SEC filings
Form Description Filed Period
10-Q Quarterly report Aug 11, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 11, 2026 Aug 11, 2026
8-K Current report
Shareholder vote results
Aug 7, 2026 Aug 7, 2026
ARS Annual report to shareholders Jun 23, 2026 Dec 31, 2025
DEFA14A Additional proxy material Jun 23, 2026 —
DEF 14A Proxy statement Jun 23, 2026 Jun 23, 2026
SD Specialized disclosure (conflict minerals) May 29, 2026 —
S-8 POS Filing May 13, 2026 —
S-8 POS Filing May 13, 2026 —
S-8 POS Filing May 13, 2026 —
S-8 POS Filing May 13, 2026 —
10-Q Quarterly report May 13, 2026 Mar 31, 2026
8-K Current report
Results of operations, Other events
May 13, 2026 May 13, 2026
8-K Current report
Regulation FD disclosure, Other events
Apr 13, 2026 Apr 10, 2026
10-K Annual report Mar 31, 2026 Dec 31, 2025
8-K Current report
Results of operations
Mar 31, 2026 Mar 31, 2026
8-K Current report
Other events
Mar 2, 2026 Mar 2, 2026
8-K Current report
Other events
Jan 16, 2026 Jan 15, 2026
8-K Current report
Acquisition or sale of assets, Regulation FD disclosure
Dec 3, 2025 Dec 1, 2025
S-8 Employee stock plan registration Nov 10, 2025 —
8-K Current report
Results of operations
Nov 10, 2025 Nov 10, 2025
10-Q Quarterly report Nov 10, 2025 Sep 30, 2025
8-K Current report
Officer or director change, Shareholder vote results
Nov 10, 2025 Nov 7, 2025
ARS Annual report to shareholders Sep 15, 2025 Dec 31, 2024
DEFA14A Additional proxy material Sep 15, 2025 —
DEF 14A Proxy statement Sep 15, 2025 Sep 15, 2025
10-Q Quarterly report Aug 12, 2025 Jun 30, 2025
8-K Current report
Results of operations, Regulation FD disclosure
Aug 12, 2025 Aug 12, 2025
8-K Current report
Other events
Aug 8, 2025 Aug 8, 2025
8-K Current report
Officer or director change
Aug 4, 2025 Aug 1, 2025
8-K Current report
Material agreement, Regulation FD disclosure, Other events
Jul 8, 2025 Jul 7, 2025
SD Specialized disclosure (conflict minerals) May 30, 2025 —
424B3 Prospectus May 20, 2025 —
EFFECT Filing May 19, 2025 —
CORRESP Letter to the SEC May 15, 2025 —
UPLOAD Letter from the SEC May 15, 2025 —
EFFECT Filing May 13, 2025 —
EFFECT Filing May 13, 2025 —
EFFECT Filing May 13, 2025 —
EFFECT Filing May 13, 2025 —
EFFECT Filing May 13, 2025 —
EFFECT Filing May 13, 2025 —
EFFECT Filing May 13, 2025 —
EFFECT Filing May 13, 2025 —
EFFECT Filing May 13, 2025 —
S-1 Registration statement May 12, 2025 —
POS AM Filing May 12, 2025 —
POS AM Filing May 12, 2025 —
POS AM Filing May 12, 2025 —
POS AM Filing May 12, 2025 —
POS AM Filing May 12, 2025 —
POS AM Filing May 12, 2025 —
POS AM Filing May 12, 2025 —
POS AM Filing May 12, 2025 —
POS AM Filing May 12, 2025 —
10-Q Quarterly report May 12, 2025 Mar 31, 2025
8-K Current report
Results of operations
May 12, 2025 May 12, 2025
8-K Current report
Agreement ended, Results of operations, Change in control, Regulation FD disclosure, Other events
Apr 16, 2025 Apr 15, 2025
8-K Current report
Material agreement
Apr 11, 2025 Apr 10, 2025
10-K Annual report Mar 6, 2025 Dec 31, 2024
8-K Current report
Results of operations
Mar 6, 2025 Mar 6, 2025
10-Q Quarterly report Nov 12, 2024 Sep 30, 2024
8-K Current report
Results of operations
Nov 12, 2024 Nov 12, 2024
EFFECT Filing Sep 11, 2024 —
424B3 Prospectus Sep 11, 2024 —
EFFECT Filing Sep 9, 2024 —
CORRESP Letter to the SEC Sep 9, 2024 —
UPLOAD Letter from the SEC Sep 9, 2024 —
POS AM Filing Sep 4, 2024 —
S-3 Shelf registration Sep 3, 2024 —
8-K Current report
Other events
Sep 3, 2024 Sep 3, 2024
D Filing Aug 12, 2024 —
8-K Current report
Material agreement, Unregistered share sale, Other events
Aug 8, 2024 Aug 7, 2024
10-Q Quarterly report Aug 8, 2024 Jun 30, 2024
8-K Current report
Results of operations
Aug 8, 2024 Aug 8, 2024
8-K Current report
Shareholder vote results
Jul 24, 2024 Jul 23, 2024
ARS Annual report to shareholders Jun 10, 2024 Dec 31, 2023
DEF 14A Proxy statement Jun 10, 2024 Jun 10, 2024
10-Q Quarterly report May 15, 2024 Mar 31, 2024
8-K Current report
Results of operations
May 15, 2024 May 15, 2024
EFFECT Filing Apr 8, 2024 —
CORRESP Letter to the SEC Apr 4, 2024 —
UPLOAD Letter from the SEC Apr 2, 2024 —
S-3 Shelf registration Apr 1, 2024 —
10-K Annual report Apr 1, 2024 Dec 31, 2023
8-K Current report
Results of operations
Apr 1, 2024 Apr 1, 2024
8-K Current report
Material agreement, New debt, Regulation FD disclosure
Mar 7, 2024 Mar 7, 2024
10-Q Quarterly report Nov 14, 2023 Sep 30, 2023
8-K Current report
Results of operations
Nov 9, 2023 Nov 9, 2023
8-K/A Amended current report Oct 26, 2023 Aug 10, 2023
8-K Current report
Regulation FD disclosure, Other events
Oct 23, 2023 Oct 23, 2023
8-K Current report
Auditor change
Aug 18, 2023 Aug 15, 2023
8-K Current report
Material agreement, Acquisition or sale of assets, Regulation FD disclosure
Aug 10, 2023 Aug 10, 2023
8-K Current report
Other events
Aug 9, 2023 Aug 8, 2023
10-Q Quarterly report Aug 1, 2023 Jun 30, 2023
8-K Current report
Results of operations
Aug 1, 2023 Aug 1, 2023
S-8 Employee stock plan registration Jul 28, 2023 —
S-8 POS Filing Jul 28, 2023 —
S-8 POS Filing Jul 28, 2023 —
S-8 POS Filing Jul 28, 2023 —
S-8 POS Filing Jul 28, 2023 —
8-K Current report
Regulation FD disclosure
Jul 28, 2023 Jul 28, 2023
8-K Current report
Officer or director change, Bylaw or fiscal year change, Shareholder vote results
Jul 28, 2023 Jul 26, 2023
424B3 Prospectus Jul 14, 2023 —
EFFECT Filing Jul 13, 2023 —
D Filing Jul 12, 2023 —
CORRESP Letter to the SEC Jul 11, 2023 —
S-3/A Filing Jul 11, 2023 —
8-K Current report
Material agreement
Jul 11, 2023 Jul 10, 2023
UPLOAD Letter from the SEC Jul 10, 2023 —
S-3 Shelf registration Jul 7, 2023 —
8-K Current report
Material agreement, Results of operations, Unregistered share sale, Regulation FD disclosure, Other events
Jul 3, 2023 Jul 3, 2023
8-K Current report
Material agreement
Jun 20, 2023 Jun 18, 2023
ARS Annual report to shareholders Jun 8, 2023 Dec 31, 2022
DEF 14A Proxy statement Jun 8, 2023 Jun 7, 2023
PRE 14A Preliminary proxy statement May 19, 2023 May 19, 2023
8-K Current report
Bylaw or fiscal year change
May 19, 2023 May 16, 2023
8-K Current report
Officer or director change, Regulation FD disclosure
May 18, 2023 May 16, 2023
8-K/A Amended current report May 16, 2023 Feb 28, 2023
10-Q Quarterly report May 4, 2023 Mar 31, 2023
8-K Current report
Results of operations
May 4, 2023 May 4, 2023
8-K Current report
Officer or director change
May 4, 2023 May 1, 2023
10-K Annual report Mar 7, 2023 Dec 31, 2022
8-K Current report
Results of operations
Mar 7, 2023 Mar 7, 2023
8-K Current report
Material agreement, Acquisition or sale of assets, New debt, Regulation FD disclosure
Mar 1, 2023 Feb 28, 2023
8-K Current report
Other events
Feb 1, 2023 Feb 1, 2023
8-K Current report
Officer or director change, Regulation FD disclosure
Jan 9, 2023 Jan 9, 2023
10-Q Quarterly report Nov 3, 2022 Sep 30, 2022
8-K Current report
Results of operations
Nov 3, 2022 Nov 3, 2022
S-8 Employee stock plan registration Oct 28, 2022 —
8-K Current report
Officer or director change, Shareholder vote results
Oct 28, 2022 Oct 26, 2022
EFFECT Filing Oct 20, 2022 —
424B3 Prospectus Oct 20, 2022 —
CORRESP Letter to the SEC Oct 18, 2022 —
UPLOAD Letter from the SEC Oct 17, 2022 —
S-3 Shelf registration Oct 11, 2022 —
8-K Current report
Unregistered share sale, Regulation FD disclosure
Oct 11, 2022 Oct 7, 2022
DEF 14A Proxy statement Sep 20, 2022 Sep 20, 2022
DEF 14C Information statement Sep 9, 2022 Sep 9, 2022
8-K Current report
Unregistered share sale, Officer or director change, Regulation FD disclosure, Other events
Aug 31, 2022 Aug 25, 2022
PRE 14C Filing Aug 30, 2022 Aug 30, 2022
D Filing Aug 26, 2022 —
8-K Current report
Material agreement, Unregistered share sale, Officer or director change, Other events
Aug 24, 2022 Aug 23, 2022
10-Q Quarterly report Aug 4, 2022 Jun 30, 2022
8-K Current report
Results of operations
Aug 4, 2022 Aug 4, 2022
10-Q Quarterly report May 5, 2022 Mar 31, 2022
8-K Current report
Results of operations
May 5, 2022 May 5, 2022
8-K Current report
Officer or director change
May 2, 2022 Apr 27, 2022
8-A12B/A Filing Mar 8, 2022 —
10-K Annual report Mar 8, 2022 Dec 31, 2021
8-K Current report
Results of operations
Mar 8, 2022 Mar 8, 2022
8-K Current report
Officer or director change, Regulation FD disclosure
Jan 3, 2022 Jan 3, 2022
10-Q Quarterly report Nov 12, 2021 Sep 30, 2021
8-K Current report
Results of operations
Nov 12, 2021 Nov 12, 2021
10-Q Quarterly report Aug 5, 2021 Jun 30, 2021
8-K Current report
Results of operations
Aug 5, 2021 Aug 5, 2021
8-K Current report
Shareholder vote results
Jul 28, 2021 Jul 27, 2021
DEF 14A Proxy statement Jun 14, 2021 Jun 14, 2021
8-K Current report
Regulation FD disclosure
May 20, 2021 May 20, 2021
EFFECT Filing May 18, 2021 —
CORRESP Letter to the SEC May 14, 2021 —
UPLOAD Letter from the SEC May 14, 2021 —
10-Q Quarterly report May 11, 2021 Mar 31, 2021
8-K Current report
Results of operations, Other events
May 11, 2021 May 11, 2021
S-3 Shelf registration May 11, 2021 —
8-K Current report
Material agreement, Agreement ended, New debt
May 6, 2021 May 6, 2021
424B3 Prospectus Apr 15, 2021 —
EFFECT Filing Apr 14, 2021 —
CORRESP Letter to the SEC Apr 12, 2021 —
UPLOAD Letter from the SEC Apr 9, 2021 —
S-3 Shelf registration Apr 6, 2021 —
EFFECT Filing Mar 3, 2021 —
D Filing Feb 26, 2021 —
POS AM Filing Feb 24, 2021 —
10-K Annual report Feb 24, 2021 Dec 31, 2020
8-K Current report
Results of operations
Feb 24, 2021 Feb 24, 2021
8-K Current report
Material agreement, Unregistered share sale, Other events
Feb 22, 2021 Feb 22, 2021
EFFECT Filing Dec 23, 2020 —
CORRESP Letter to the SEC Dec 22, 2020 —
UPLOAD Letter from the SEC Dec 22, 2020 —
DEL AM Filing Dec 22, 2020 —
S-1 Registration statement Dec 18, 2020 —
8-K Current report
Regulation FD disclosure
Dec 7, 2020 Dec 7, 2020
8-K Current report
Unregistered share sale
Nov 19, 2020 Nov 17, 2020
424B3 Prospectus Nov 5, 2020 —
EFFECT Filing Nov 3, 2020 —
CORRESP Letter to the SEC Oct 30, 2020 —
S-1/A Amended registration statement Oct 30, 2020 —
S-8 Employee stock plan registration Oct 30, 2020 —
10-Q Quarterly report Oct 29, 2020 Sep 30, 2020
8-K Current report
Results of operations
Oct 29, 2020 Oct 29, 2020
8-K Current report
Officer or director change, Shareholder vote results
Oct 28, 2020 Oct 27, 2020
8-K Current report
Other events
Oct 22, 2020 Oct 22, 2020
8-K Current report
Other events
Oct 6, 2020 Oct 6, 2020
D Filing Oct 5, 2020 —
8-K Current report
Material agreement, Results of operations, Unregistered share sale, Bylaw or fiscal year change, Regulation FD disclosure, Other events
Oct 1, 2020 Oct 1, 2020
UPLOAD Letter from the SEC Sep 15, 2020 —
S-1 Registration statement Sep 11, 2020 —
DEF 14A Proxy statement Sep 10, 2020 Sep 10, 2020
DEF 14C Information statement Sep 10, 2020 Sep 10, 2020

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Surgical & Medical Instruments & Apparatus (SIC 3841)
Listed as
XTNT (NYSE)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Belgrade, MT
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1453593
Former names
Bacterin International Holdings, Inc. (until Aug 3, 2015); K KITZ INC (until May 21, 2010)

Other Surgical & Medical Instruments & Apparatus companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.